受试者-在线临床试验
Published by: Shanghai Yongzheng Curative Science And Technology Co
Description
受试者APP是用正医药研发的全方位临床试验研究软件套件中的受试者终端，可以帮助受试者轻松联系临床试验研究者，提供文字、语音和视频等多种沟通手段，同时可提供在线访视预约及提醒、服药提醒等功能。
Screenshots
受试者-在线临床试验 FAQ
-
Is 受试者-在线临床试验 free?
Yes, 受试者-在线临床试验 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 受试者-在线临床试验 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 受试者-在线临床试验 cost?
受试者-在线临床试验 is free.
-
What is 受试者-在线临床试验 revenue?
To get estimated revenue of 受试者-在线临床试验 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Australia yet.
Ratings History
受试者-在线临床试验 Reviews
No Reviews in Australia
App doesn't have any reviews in Australia yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
受试者-在线临床试验 Installs
Last 30 days
受试者-在线临床试验 Revenue
Last 30 days受试者-在线临床试验 Revenue and Downloads
Gain valuable insights into 受试者-在线临床试验 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Business
- Languages
- English
- Recent release
- 1.1.0 (1 year ago )
- Released on
- Aug 12, 2021 (3 years ago )
- Also available in
- United States, China, Mexico, Philippines, Peru, New Zealand, Norway, Netherlands, Nigeria, Malaysia, Poland, Lebanon, Kazakhstan, Kuwait, South Korea, Japan, Italy, Pakistan, India, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, Colombia, Czechia, Germany, Denmark, United Arab Emirates, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel
- Last Updated
- 2 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.